Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

The American Journal of Physiology - Renal Physiology (ISSN: 1931-857X; E-ISSN: 1522-1466), published by the esteemed American Physiological Society, serves as a premier platform for disseminating significant research in the field of renal physiology. This journal, recognized for its high impact factor and classified in the Q1 category for both Physiology and Urology as of 2023, showcases innovative studies, reviews, and critical commentaries that deepen our understanding of kidney function and its implications on overall health. With coverage extending from 1977 to 2024, the journal is crucial for researchers, clinicians, and students who are eager to explore the latest findings and advancements in renal research. Although it does not provide Open Access options, the journal's commitment to rigorous peer review ensures that only the highest quality of scientific inquiry reaches its audience, solidifying its reputation as a vital resource in the field.

RENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.

Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

TERAPEVTICHESKII ARKHIV, published by CJSC CONSILIUM MEDICUM, is a distinguished open-access journal that has been pivotal in the fields of Endocrinology, Family Practice, History, and Internal Medicine since its inception in 1949. Recognized in 2023 with quartile rankings of Q3 in Family Practice and notable placements in other categories, the journal aims to disseminate high-quality research, innovative treatment methods, and comprehensive reviews that advance the understanding of medical practices and historical contexts within these disciplines. With its commitment to accessibility, as demonstrated by its open-access policy initiated in 2018, TERAPEVTICHESKII ARKHIV serves as an invaluable resource for researchers, healthcare professionals, and students looking to stay abreast of cutting-edge advances and historical perspectives in medicine, especially within the Russian Federation. The journal’s focus on interdisciplinary approaches encourages a rich dialogue across various medical fields, underlining its significance in fostering a well-rounded academic community.